Ann: Return of Capital - MYX (updated), page-66

I believe Mayne has and still is being destroyed
by our association with Mithra Pharmaceutical.
Either our previous CEO was complicit or hoodwinked
by Mithra initially regarding Haloette then Nextellis
followed by future menopausal products. It has been
a complete disaster. Not only is Fornieri ( past Business
man of the year in Belgium) a criminal in public company
trading he is also a conman. Scott Richards and former
board members allowed this seriously bad culture
to begin, then mature under their watch now they have
taken their I’ll gotten gains and gone, but the cultural
remnants remain.
The sales and marketing of Nextellis is a now obvious
failure. Using 40-50 year old methods at hugely
unsustainable costs in this day and age is madness.
This can only happen when using others money and
there are no consequences. The most recent contraceptive pill to be released from my quick internet
enquiry is LOVIMA. £8.95. The total marketing is
on the net. Answer a few simple questions. Should
you require a prescription . A doctor calls you ( done)
Product arrives in the mail . No free samples for 3
months. No seminars held all over the country. Anyway
why would we take on a product if there were already
30-40 already available. They all seem to work, I haven’t
heard of any serious problems with the pill in 60 y.
Nextellis is no cure for cancer and from my reviewing
reviews and difficulty in getting supply as well as the COST personally I would buy LOVIMA .From all accounts we are holding Nextellis as the Holy Grail
and spending $millions more on products to complement
it. I will bet the latest little pill will gain a far greater
market share in next two years than Nextellis has
I truly believe current leadership of Mayne believes
the same and for whatever reason they will see the
demise of Mayne if it continues.